Sponsor of the Day:
Jerkmate
https://www.fredhutch.org/en/diseases/myeloproliferative-neoplasms.html
Myeloproliferative Neoplasms - Fred Hutch
Fred Hutch experts offer comprehensive care for MPN, including advanced treatments. Many MPN patients join clinical trials, which are led by world-renowned...
myeloproliferative neoplasmsfred hutch
https://www.healio.com/news/hematology-oncology/myeloproliferative-neoplasms
Myeloproliferative Neoplasms News
Find the latest Myeloproliferative Neoplasms news articles, videos, podcasts, and meeting coverage from medical experts and key opinion leaders you trust.
myeloproliferative neoplasmsnews
https://www.cancerresearchuk.org/about-cancer/myeloproliferative-neoplasms
Myeloproliferative neoplasms | Cancer Research UK
Myeloproliferative neoplasms are a group of rare disorders of the bone marrow that cause an increase in the number of blood cells.
cancer research ukmyeloproliferative neoplasms
https://www.nature.com/articles/s41467-025-60884-1?error=cookies_not_supported&code=cd882ef6-bfda-43ae-a35e-0edb9b8944f8
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms...
Jul 8, 2025 - JAK (Janus Kinase) inhibitors, such as ruxolitinib, were introduced a decade ago for treatment of myeloproliferative neoplasms (MPN). To evaluate ruxolitinib’s...
myeloproliferative neoplasmsinhibitionmediatesclonalselection
https://link.springer.com/article/10.1007/s00428-012-1272-5?error=cookies_not_supported&code=7246ef7a-9c98-4dd1-ba8a-a61cebc4dd87
Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach |...
Jul 11, 2012 - The enzyme alpha-methylacyl-coenzyme A racemase plays an important role in the beta-oxidation of branched-chain fatty acid and its derivatives. It has been
alphacoenzymeexpressionneuroendocrineneoplasms
https://www.academia.edu/84489851/Treatment_of_Patients_With_Spinal_Metastases_From_Head_and_Neck_Neoplasms
(PDF) Treatment of Patients With Spinal Metastases From Head and Neck Neoplasms
Nov 24, 2024 - Background: Spinal metastases are uncommon in patients with advanced head and neck cancer. Treatment strategies in this patient group have not been defined....
pdftreatmentpatientsspinalmetastases